Emmanuelle Boishardy – General Manager, GSK Czech Republic
Emmanuelle Boishardy joined GSK in France 20 years ago. In 2017, she embarked on her first assignment as General Manager – in the Czech affiliate. She recounts how she adapted…
Institute of Health Information and Statistics of the Czech Republic (further on “the Institute“) was established in 1960. The Institute is an organisational component of the State; its founder is the Ministry of Health.
The National Health Information System (further on “NHIS“) is defined in Act no. 372/2011Sb, On health services and conditions of their provision (Act on health services) in Section 70, paragraph 1 (the Act is valid since April. 2012).
Administration of NHIS is delegated by MH to the Institute in accordance with the basic purpose and objective of its activity that follows from the Statute of the Institute. The extent of the mandate of the Institute is defined in Section 72, paragraph 1, letters a) to d) and f) of Act no. 372/2011Sb, on health services.
In handling personal data in NHIS the Institute proceeds in accordance with Act no. 101/2000 Sb., On personal data protection, in wording of later regulations.
The Institute is a component of the State Statistical Service (on the basis of the competence act) and performs this activity according to Act no. 89/1995 Sb., On state statistical service, in wording of later regulations. It cooperates with organs of State Statistical Service, mainly with Czech Statistical Office, it secures connection between NHIS and individual health care providers and it cooperates with the operators of information systems of other organisations in and out of the health sector.
The Institute will continue to follow the principles of the European Statistics Code of Practice that represents the common summary of European standards designated for statistical organs and for the whole European statistical system with the aim to secure high quality and credibility of European data. These principles concern, among other things, professional independence, confidentiality protection, reliability of the data and their precision, timeliness, punctuality, accessibility, intelligibility, clarity, comparability and consistency.
The Institute cooperates with associations of hospitals, associations of physicians, professional medical societies, health insurance companies and other organisations, particularly on precise specification of the NHIS contents and on utilisation of the collected data.
On the international level of health statistics the Institute cooperates particularly with WHO, OECD, the UN, EUROSTAT and other organisations. The Institute is the official presenter of NHIS data for the Czech Republic.
Contact
Institute of health information and statistics of the Czech Republic
Palackého nám. 4 , P.O.BOX 60,
128 01 Praha
email: uzis@uzis.cz
Emmanuelle Boishardy joined GSK in France 20 years ago. In 2017, she embarked on her first assignment as General Manager – in the Czech affiliate. She recounts how she adapted…
With a footprint of over 20 years in the Czech Republic, Gedeon Richter’s affiliate here is a key pillar to the company’s success in the Central Eastern European region. Corina…
Josef Kredba, country manager Czech Republic at G.L. Pharma, an Austrian pharmaceutical company, explains how the company has returned to growth in the challenging Czech generics market and shares his…
Jan Škrha, president of the Czech Diabetes Society (ČDS), provides insight into the most crucial advances in the quality care of Diabetes, which relies on the indispensable cooperation between specialists…
Here we highlight five of the most important women working in healthcare and the life sciences in Central & Eastern Europe (CEE) today. From regulators to pharma affiliate heads with…
Tomáš Votruba of the Association of Full-Line Wholesalers (AVEL), which gathers the three major players of the pharmaceutical distribution market in the Czech Republic, gives an overview of the current…
Tomáš Dolezal, president of the International Society for Pharmacoeconomics and Outcomes (ISPOR) Czech Regional Chapter and director of the Institute of Health Economics and Technology Assessment (iHETA), gives an overview…
Sandoz’s Jiří Hanzlík, country head for the Czech Republic, evaluates the Czech affiliate’s role in contributing to the success of Sandoz globally as well as its position in the country.…
Jakub Dvořáček, CEO of the Czech Association of Innovative Pharmaceutical Industry (AIFP), describes the thorough review of the reimbursement scheme the association has worked on alongside other key stakeholders in…
Bioinova’s CEO and managing director MUDr Peter Bauer PhD introduces the biotech company’s shift from a university spin-off to a privately held entity. Whilst describing the powerful properties of stem…
Štěpán Svačina, Chairman of the Czech Medical Association (CzMA), gives insights into the challenges that the Czech Republic faces in bringing change to the life sciences infrastructure. Whilst pointing out…
The Czech Republic’s Minister of Health, Adam Vojtěch, is the youngest in the country’s history and has set out an ambitious reform programme to improve the state of the Czech…
See our Cookie Privacy Policy Here